SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 71 filers reported holding SERES THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.53 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $20,848,000 | +44.6% | 874,124 | +24.9% | 0.05% | +35.1% |
| Q1 2021 | $14,414,000 | -55.7% | 700,049 | -47.3% | 0.04% | -57.0% |
| Q4 2020 | $32,533,000 | +258.1% | 1,327,897 | +313.7% | 0.09% | +196.6% |
| Q3 2020 | $9,086,000 | +212.4% | 320,944 | +287.3% | 0.03% | +222.2% |
| Q4 2015 | $2,908,000 | -58.2% | 82,873 | -64.7% | 0.01% | -57.1% |
| Q3 2015 | $6,958,000 | +4.8% | 234,730 | +46.7% | 0.02% | +16.7% |
| Q2 2015 | $6,640,000 | – | 160,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |